Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemiasM H Woo, M V Relling, D S Sonnichsen, et al.
Cancer|November 1, 1994
Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumorsC B Pratt, W H Meyer, N Howlett, et al.
Cancer Treatment Reports|June 1, 1986
Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adultsJ S Holcenberg, K D Tutsch, R H Earhart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicityM P Goren, A A Forastiere, R K Wright, et al.
Journal of Pediatric Hematology/Oncology|August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Yanofsky, S Pritchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of topotecan for pediatric patients with malignant solid tumorsC B Pratt, C Stewart, V M Santana, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|May 23, 1998
Patient satisfaction after limb-sparing surgery and amputation for pediatric malignant bone tumorsM M Hudson, V L Tyc, L K Cremer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesnaC B Pratt, A A Green, M E Horowitz, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.
Cancer|March 1, 1993
Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II studyF H Kung, C B Pratt, R A Vega, et al.
Pageof 27